The Global Medicines Supply Chain

The global medicines supply chain is vulnerable to disruptions that lead to drug shortages as well as increases in substandard and counterfeit medicines. Solutions are needed to strengthen it. A strong and resilient supply chain ensures patients receive the medicines needed when they are needed, they work as they should and do not cause unnecessary harm.

USP standards build public trust in medicines, and are an important resource in the medicine supply chain safety net to ensure safe, quality medicines reach patients.

Additional supply chain strengthening solutions include:

  • Working with stakeholders to modernize pharmaceutical manufacturing and build production capacity globally
  • Using data to better understand and fix weaker links in the supply chain
  • Advocating for strong quality systems all along the supply chain.
advanced manufacturing
Strengthening the medicines supply chain through advanced manufacturing technology
rows of pills
Medicine Supply Map: Insights that can guide risk mitigation strategies
supply chain issues

Building greater resilience in the supply chain

Read the policy paper

USP is applying its knowledge in medicine standards to new solutions to make the supply chain more resilient. Our scientists are developing standards to aid in modernizing pharmaceutical manufacturing, which aims to increase overall medicine production capability, expand pharmaceutical manufacturing to more regions to reduce over-reliance on sourcing from a few countries, and increase the overall quality of medicines as well as quality control processes. USP is gleaning insights from data on standards distribution and usage in order to develop an early-warning capability for potential disruptions in the upstream medicines supply chain.

Sign up to receive resources and updates related to USP’s work to strengthen the global supply of medicine